)
Edge3 Apr 2026
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
IceCure Medical
IceCure Medical (ICCM) investor relations material
IceCure Medical Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary1 Apr, 2026
Company overview and business model
Commercial-stage medical device company specializing in cryoablation systems using liquid nitrogen for tumor treatment, offering minimally invasive alternatives to surgery for various tumor types including breast, lung, kidney, and bone.
Lead product, ProSense system, is FDA-authorized for local treatment of low-risk breast cancer in women aged 70+ with adjuvant endocrine therapy.
Operations are based in Israel with subsidiaries in the US, Hong Kong, and China; listed on Nasdaq and Tel Aviv Stock Exchange.
Financial performance and metrics
As of December 31, 2025, cash and cash equivalents were $8.9 million; pro forma as adjusted for recent offerings, cash would be $21.2 million.
Shareholders' equity as of December 31, 2025, was $9.1 million, increasing to $21.4 million pro forma as adjusted.
March 2026 offering raised gross proceeds of $4.0 million, with potential for an additional $8.8 million if all warrants are exercised.
Use of proceeds and capital allocation
No proceeds from resale of shares by selling shareholders; proceeds from warrant exercises will be used for working capital and general corporate purposes.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from IceCure Medical
- Medtech firm seeks $100M for growth, facing legal and market risks.ICCM
Registration filing20 Mar 2026 - Record revenue and regulatory milestones drive rapid adoption and improved financial outlook.ICCMQ4 202517 Mar 2026
- FDA review of ProSense post-market study advances, with stable Q1 revenue and improved cash flexibility.ICCMQ1 202517 Mar 2026
- First FDA-cleared minimally invasive cryoablation for breast cancer, poised for rapid global growth.ICCMCompany presentation16 Mar 2026
- Emerging growth company files Form F-3 for flexible U.S. securities offerings.ICCMRegistration Filing16 Mar 2026
- Sales up 20%, net loss narrows, FDA and Japan reviews expected by early 2025.ICCMQ2 202423 Jan 2026
- 36% sales growth, margin gains, and FDA panel support set up major 2025 milestones.ICCMQ3 202412 Jan 2026
- Sales up 8% and North America grew 42%; FDA decision could further accelerate adoption.ICCMQ4 202426 Dec 2025
- Offering up to $100M in securities, with proceeds for operations and R&D amid geopolitical risks.ICCMRegistration Filing16 Dec 2025
Next IceCure Medical earnings date
Q1 202627 May, 2026
IceCure Medical
Next IceCure Medical earnings date
Q1 202627 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage